US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist
  • 0.970
  • +0.060+6.59%
Trading Dec 26 14:50 ET
63.90MMarket Cap-0.75P/E (TTM)

IO Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
12.86%26.5M
-1.46%21.53M
12.68%20.2M
28.03%91.44M
38.23%28.18M
48.02%23.48M
20.32%21.85M
5.37%17.92M
73.22%71.42M
-4.70%20.39M
Selling and administrative expenses
8.53%6.33M
6.30%5.69M
-2.29%5.89M
-3.37%23.61M
7.67%6.41M
-0.24%5.83M
-9.89%5.35M
-10.14%6.02M
120.52%24.44M
20.20%5.96M
-General and administrative expense
8.53%6.33M
6.30%5.69M
-2.29%5.89M
-3.37%23.61M
7.67%6.41M
-0.24%5.83M
-9.89%5.35M
-10.14%6.02M
120.52%24.44M
20.20%5.96M
Research and development costs
14.29%20.18M
-3.97%15.85M
20.26%14.31M
44.36%67.83M
50.83%21.77M
76.16%17.66M
34.99%16.5M
15.47%11.9M
55.83%46.99M
-12.21%14.43M
Operating profit
-12.86%-26.5M
1.46%-21.53M
-12.68%-20.2M
-28.03%-91.44M
-38.23%-28.18M
-48.02%-23.48M
-20.32%-21.85M
-5.37%-17.92M
-73.22%-71.42M
4.70%-20.39M
Net non-operating interest income expense
-37.47%1.07M
9.62%1.31M
57.30%1.62M
430.30%5.88M
148.91%1.95M
350.66%1.71M
2,035.71%1.2M
1,051.85%1.03M
407.20%1.11M
618.54%783K
Non-operating interest income
-37.47%1.07M
9.62%1.31M
57.30%1.62M
316.80%5.88M
149.87%1.95M
273.74%1.71M
656.96%1.2M
6,753.33%1.03M
--1.41M
--780K
Non-operating interest expense
----
----
----
--0
----
----
----
----
-16.34%302K
-101.99%-3K
Other net income (expense)
576.61%1.63M
-1,000.00%-90K
-279.07%-462K
154.62%331K
-22.41%405K
-293.10%-342K
103.50%10K
1,390.00%258K
100.50%130K
71.15%522K
Gain on sale of security
576.61%1.63M
-1,000.00%-90K
-279.07%-462K
154.62%331K
-22.41%405K
-293.10%-342K
103.50%10K
1,390.00%258K
-59.25%130K
5,120.00%522K
Income before tax
-7.63%-23.81M
1.62%-20.31M
-14.45%-19.04M
-21.44%-85.23M
-35.34%-25.83M
-42.03%-22.12M
-12.26%-20.65M
2.92%-16.64M
-3.50%-70.19M
10.15%-19.08M
Income tax
147.61%209K
-29.70%374K
2.22%415K
-33.07%852K
-64.24%353K
-481.74%-439K
411.54%532K
515.15%406K
1,772.06%1.27M
1,351.47%987K
Net income
-10.78%-24.02M
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
Net income continuous Operations
-10.78%-24.02M
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
Minority interest income
Net income attributable to the parent company
-10.78%-24.02M
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.78%-24.02M
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
4.71%-71.46M
10.44%-20.07M
Basic earnings per share
16.28%-0.36
58.11%-0.31
49.15%-0.3
20.16%-1.98
43.23%-0.3974
20.37%-0.43
-15.63%-0.74
1.67%-0.59
85.66%-2.48
10.00%-0.7
Diluted earnings per share
16.28%-0.36
58.11%-0.31
49.15%-0.3
20.16%-1.98
43.23%-0.3974
20.37%-0.43
-15.63%-0.74
1.67%-0.59
85.66%-2.48
10.00%-0.7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 12.86%26.5M-1.46%21.53M12.68%20.2M28.03%91.44M38.23%28.18M48.02%23.48M20.32%21.85M5.37%17.92M73.22%71.42M-4.70%20.39M
Selling and administrative expenses 8.53%6.33M6.30%5.69M-2.29%5.89M-3.37%23.61M7.67%6.41M-0.24%5.83M-9.89%5.35M-10.14%6.02M120.52%24.44M20.20%5.96M
-General and administrative expense 8.53%6.33M6.30%5.69M-2.29%5.89M-3.37%23.61M7.67%6.41M-0.24%5.83M-9.89%5.35M-10.14%6.02M120.52%24.44M20.20%5.96M
Research and development costs 14.29%20.18M-3.97%15.85M20.26%14.31M44.36%67.83M50.83%21.77M76.16%17.66M34.99%16.5M15.47%11.9M55.83%46.99M-12.21%14.43M
Operating profit -12.86%-26.5M1.46%-21.53M-12.68%-20.2M-28.03%-91.44M-38.23%-28.18M-48.02%-23.48M-20.32%-21.85M-5.37%-17.92M-73.22%-71.42M4.70%-20.39M
Net non-operating interest income expense -37.47%1.07M9.62%1.31M57.30%1.62M430.30%5.88M148.91%1.95M350.66%1.71M2,035.71%1.2M1,051.85%1.03M407.20%1.11M618.54%783K
Non-operating interest income -37.47%1.07M9.62%1.31M57.30%1.62M316.80%5.88M149.87%1.95M273.74%1.71M656.96%1.2M6,753.33%1.03M--1.41M--780K
Non-operating interest expense --------------0-----------------16.34%302K-101.99%-3K
Other net income (expense) 576.61%1.63M-1,000.00%-90K-279.07%-462K154.62%331K-22.41%405K-293.10%-342K103.50%10K1,390.00%258K100.50%130K71.15%522K
Gain on sale of security 576.61%1.63M-1,000.00%-90K-279.07%-462K154.62%331K-22.41%405K-293.10%-342K103.50%10K1,390.00%258K-59.25%130K5,120.00%522K
Income before tax -7.63%-23.81M1.62%-20.31M-14.45%-19.04M-21.44%-85.23M-35.34%-25.83M-42.03%-22.12M-12.26%-20.65M2.92%-16.64M-3.50%-70.19M10.15%-19.08M
Income tax 147.61%209K-29.70%374K2.22%415K-33.07%852K-64.24%353K-481.74%-439K411.54%532K515.15%406K1,772.06%1.27M1,351.47%987K
Net income -10.78%-24.02M2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M
Net income continuous Operations -10.78%-24.02M2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M
Minority interest income
Net income attributable to the parent company -10.78%-24.02M2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.78%-24.02M2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M4.71%-71.46M10.44%-20.07M
Basic earnings per share 16.28%-0.3658.11%-0.3149.15%-0.320.16%-1.9843.23%-0.397420.37%-0.43-15.63%-0.741.67%-0.5985.66%-2.4810.00%-0.7
Diluted earnings per share 16.28%-0.3658.11%-0.3149.15%-0.320.16%-1.9843.23%-0.397420.37%-0.43-15.63%-0.741.67%-0.5985.66%-2.4810.00%-0.7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data